Accessibility Menu
 
Theralink Technologies logo

Theralink Technologies

(OTC) THER

Current Price$0.00
Market Cap$6,200
Since IPO (2015)-100%
5 Year-100%
1 Year-99%
1 Month+0%

Theralink Technologies Financials at a Glance

Market Cap

$6,200

Revenue (TTM)

$753.95K

Net Income (TTM)

$1.26M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-0.97 (Low)

Price

$0.00

Volume

51

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

THER News

No articles available.

THER: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Theralink Technologies

Industry

Biotechnology

Employees

16

CEO

Faith Zaslavsky

Headquarters

Golden, CO 80401, US

THER Financials

Key Financial Metrics (TTM)

Gross Margin

79%

Operating Margin

-15%

Net Income Margin

-51%

Return on Equity

0%

Return on Capital

24%

Return on Assets

-11%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

-0.09%

Stock Overview

Market Cap

$6.20K

Shares Outstanding

6.15B

Volume

51

Short Interest

0.00%

Avg. Volume

41.81K

Financials (TTM)

Gross Profit

$480.56K

Operating Income

$8.98M

EBITDA

$8.73M

Operating Cash Flow

$5.77M

Capital Expenditure

$163.38K

Free Cash Flow

$5.94M

Cash & ST Invst.

$998.28K

Total Debt

$19.76M

Theralink Technologies Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2023YOY CHG

Revenue

$179.27K

-41.3%

Gross Profit

$139.36K

-42.1%

Gross Margin

77.74%

N/A

Market Cap

$6.20K

N/A

Market Cap/Employee

$387.50

N/A

Employees

16

N/A

Net Income

$9.62M

+225.1%

EBITDA

$2.48M

+65.8%

Quarterly Fundamentals

Name
Q4 2023YOY CHG

Net Cash

$18.76M

-371.7%

Accounts Receivable

$23.91K

-25.6%

Inventory

$0.00

N/A

Long Term Debt

$1.13M

-61.6%

Short Term Debt

$18.63M

+1202.4%

Return on Assets

-10.85%

N/A

Return on Invested Capital

24.28%

N/A

Free Cash Flow

$1.66M

-70.6%

Operating Cash Flow

$1.50M

-61.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NSHSFNanoSphere Health Sciences Inc.
$0.10+900.00%
BVAXFBioVaxys Technology Corp.
$0.06+8.38%
BIXTBioxytran, Inc.
$0.04+8.72%
BZYRBurzynski Research Institute, Inc.
$0.03+25.65%

Trending Stocks

Symbol / CompanyPricePrice Chg
UGROUrban-gro
$6.21+1.85%
TQQQProShares Trust - ProShares UltraPro Qqq
$45.12+0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.97+0.07%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.49-0.04%

Questions About THER

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.